MedPath
FDA Approval

Pentobarbital Sodium

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Effective Date
January 10, 2023
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Pentobarbital(50 mg in 1 mL)

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Pentobarbital Sodium

Product Details

NDC Product Code
24201-010
Application Number
ANDA203619
Marketing Category
ANDA (C73584)
Route of Administration
INTRAMUSCULAR, INTRAVENOUS
Effective Date
January 10, 2023
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3Class: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
ALCOHOLInactive
Code: 3K9958V90MClass: IACT
Code: NJJ0475N0SClass: ACTIBQuantity: 50 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath